Mechanistic Modeling of Central Nervous System Pharmacokinetics and Target Engagement of HER2 Tyrosine Kinase Inhibitors to Inform Treatment of Breast Cancer Brain Metastases

PURPOSE: This study evaluated the central nervous system (CNS) pharmacokinetics and target engagement of lapatinib, neratinib, and tucatinib in patients with cancer, using a physiologically based pharmacokinetic (PBPK) modeling approach. EXPERIMENTAL DESIGN: Drug-specific parameters for in vitro met...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jing, Jiang, Jun, Bao, Xun, Kumar, Vineet, Alley, Stephen C., Peterson, Scott, Lee, Anthony J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2022
Materias:
Translational Cancer Mechanisms and Therapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357092/
https://www.ncbi.nlm.nih.gov/pubmed/35727144
http://dx.doi.org/10.1158/1078-0432.CCR-22-0405

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9357092/
https://www.ncbi.nlm.nih.gov/pubmed/35727144
http://dx.doi.org/10.1158/1078-0432.CCR-22-0405

Ejemplares similares